Nasdaq

Elanco Receives FDA Approval for Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets), the Broadest(i) Canine Oral Parasiticide Protection ...

Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) is the first and only canine oral parasiticide to protect against six parasites, including fleas, ticks, ...
Finanznachrichten

Elanco Animal Health: Elanco's Credelio Quattro-CA1 (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Receives First FDA Conditional Approval for Treatment ...

INDIANAPOLIS, Dec. 18, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) for ...
Insurancenewsnet.com

MSD Animal Health Receives Positive Opinion from European Medicines Agency for BRAVECTO® Plus (fluralaner plus moxidectin) Spot-on Solution for Cats

MADISON, N.J.--(BUSINESS WIRE)-- MSD Animal Health (known as Merck Animal Health in the United States and Canada) today announced that the Committee for Medicinal Products for Veterinary Use (CVMP) of ...
Pharmabiz

Boehringer Ingelheim gets US FDA approval for NexGard PLUS, a beef-flavoured soft chew that protects dogs from internal and external parasites

Boehringer Ingelheim announced that the US Food and Drug Administration (FDA) has approved the newest innovation from the trusted NexGard Brand of Products — NexGard PLUS (afoxolaner, moxidectin and ...